ECSP23019850A - GLP-1/GIP DUAL AGONISTS - Google Patents

GLP-1/GIP DUAL AGONISTS

Info

Publication number
ECSP23019850A
ECSP23019850A ECSENADI202319850A ECDI202319850A ECSP23019850A EC SP23019850 A ECSP23019850 A EC SP23019850A EC SENADI202319850 A ECSENADI202319850 A EC SENADI202319850A EC DI202319850 A ECDI202319850 A EC DI202319850A EC SP23019850 A ECSP23019850 A EC SP23019850A
Authority
EC
Ecuador
Prior art keywords
glp
dual agonists
gip
obesity
gip dual
Prior art date
Application number
ECSENADI202319850A
Other languages
Spanish (es)
Inventor
Abhishek Tiwari
Manish Harendraprasad Gandhi
Rajamannar Thennati
Muthukumaran Natarajan
Krunal Harishbhai Soni
Dhiren Rameshchandra Joshi
Chandulal Thakarshibhai Jivani
Vinod Sampatrao Burade
Original Assignee
Sun Pharmaceutical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Ind Ltd filed Critical Sun Pharmaceutical Ind Ltd
Publication of ECSP23019850A publication Critical patent/ECSP23019850A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a polipéptidos duales de acción prolongada agonistas del péptido 1 similar al glucagón y del polipéptido insulinotrópico dependiente de glucosa (GIP) humano que pueden usarse para tratar la diabetes mellitus tipo 2 (T2D), la diabetes con obesidad, la obesidad y la hiperlipidemia.The present invention relates to dual long-acting agonist glucagon-like peptide 1 and human glucose-dependent insulinotropic polypeptide (GIP) polypeptides that can be used to treat type 2 diabetes mellitus (T2D), diabetes with obesity, obesity and hyperlipidemia.

ECSENADI202319850A 2020-10-17 2023-03-21 GLP-1/GIP DUAL AGONISTS ECSP23019850A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN202021045240 2020-10-17

Publications (1)

Publication Number Publication Date
ECSP23019850A true ECSP23019850A (en) 2023-05-31

Family

ID=85131249

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202319850A ECSP23019850A (en) 2020-10-17 2023-03-21 GLP-1/GIP DUAL AGONISTS

Country Status (2)

Country Link
AR (1) AR123791A1 (en)
EC (1) ECSP23019850A (en)

Also Published As

Publication number Publication date
AR123791A1 (en) 2023-01-11

Similar Documents

Publication Publication Date Title
CO2023001960A2 (en) dual glp-1/gip agonists
CL2022003654A1 (en) Long-acting glp-1/gip dual agonists
ECSP17043648A (en) GIP AND GLP-1 CO-AGONIST COMPOUNDS
MY197569A (en) Gip/glp1 co-agonist compounds
CL2021003419A1 (en) Glucagon-like peptide-1 receptor agonists
BRPI0924307A8 (en) OXINTOMODULIN ANALOGS
AR064032A1 (en) THERAPEUTIC USES OF HETEROLOGICAL POLYPEPTIDES IL-17A / F
AR099977A1 (en) DOUBLE PEPTIDE AGONISTS OF THE RECIPIENTS OF THE SIMILAR PEPTIDE TO GLUCAGON 1 (GLP-1) AND OF THE GLUCAGON RECEIVER (GCG), DERIVED FROM EXENDINA-4
CL2011003173A1 (en) Glucagon analog, gip and glp-1 agonist; dimer comprising the glucagon analog; conjugated to the analog; composition comprising said analog; use to prepare a medicine to treat diabetes, reduce weight gain, or induce weight loss.
EP2070946A3 (en) Invention affecting GLP-1 and Exendin
MX2021005725A (en) Treatment of obesity and its complications.
EA202191379A1 (en) COMBINED NAFLD AND NASH TREATMENT
ECSP23019850A (en) GLP-1/GIP DUAL AGONISTS
BR112023024968A2 (en) TREATMENT OF OBESITY AND OBESITY-RELATED DISORDERS
WO2023111278A3 (en) Peptides triple agonists of gip, glp-1 and glp-2
MX2015009433A (en) Novel polypeptides having satiety hormone releasing activity.
RU2015129010A (en) Derived insulinotropic peptide with a modified N-terminal charge
TH172514A (en) Compounds work together GIP and GLP-1.